Two Congressional committees have held hearings on the need for lowering prescription drug costs. Issues facing the people with diabetes who need insulin to stay alive or simply assist their control of the condition were mentioned frequently in discussions.
Congressional Diabetes Caucus Co-Chair, Rep. Diana DeGette gave members an insight into the issues at a time when Congress is considering various forms of legislation to address prescription drug affordability.
Advocacy Action: Is insulin pricing an issue where you are? Is there a patient action group like DPAC (Diabetes Patient Advocacy Coalition) in the US, whom you could help by raising questions, contributing to or initiating debates, or helping to publicise?